Long-term use and cost-effectiveness of secondary prevention drugs for heart disease in Western Australian seniors (WAMACH): a study protocol.
Anthony S GunnellMatthew W KnuimanElizabeth GeelhoedMichael S T HobbsJudith M KatzenellenbogenJoseph HungJamie M RankinLee NedkoffThomas G BriffaMichael OrtizMalcolm GilliesAnne CordingleyMitch MesserChristian GardnerDerrick LopezEmily AtkinsQun MaiFrank M SanfilippoPublished in: BMJ open (2014)
Human Research Ethics Committee (HREC) approvals have been obtained from the Department of Health (Western Australian #2011/62 and Federal) and the University of Western Australia (RA/4/1/1130), in addition to HREC approvals from all participating hospitals. Findings will be published in peer-reviewed medical journals and presented at local, national and international conferences. Results will also be disseminated to consumer groups.
Keyphrases
- healthcare
- south africa
- public health
- study protocol
- endothelial cells
- health information
- randomized controlled trial
- rheumatoid arthritis
- mental health
- clinical trial
- pulmonary hypertension
- big data
- machine learning
- induced pluripotent stem cells
- disease activity
- systematic review
- risk assessment
- human health
- drug induced
- deep learning
- climate change
- double blind